| Literature DB >> 29854613 |
Seyedeh Mahsa Poormoosavi1, Hosein Najafzadehvarzi2, Mohammad Amin Behmanesh1, Reza Amirgholami3.
Abstract
Asparagus officinalis is an herbal medicine with remarkable antioxidant, anti-inflammatory, and antihepatotoxic properties. The present study aimed to investigate whether Bisphenol A (BPA) could induce histopathological changes and oxidative stress in the liver and kidney tissues of male rats. In addition, we evaluated whether the co-administration of the Asparagus officinalis extract (AOE) could prevent the possible damages. In total, 40 adult male Wistar rats with the mean weight of 200 ± 20 grams were divided into five groups. Control subjects were placed in the first group, while group two was the vehicle (5 ml/kg bwt/day). Subjects in group three were administered with 400 mg/kg of AOE (bwt/day), group four received 10 mg/kg of BPA (bwt/day) dissolved in 5 ml/kg of olive oil, and group five received oral BPA and AOE daily for eight weeks. After the experiments, the blood, liver, and kidneys of the animals were collected and examined. Biochemical results showed a significant elevation in the levels of liver and kidney biomarkers in the BPA group (P ≤ 0.05). Moreover, malondialdehyde was observed to increase, while thiol protein and total antioxidant capacity decreased. Histopathological results of the BPA group indicated dilated and congested central and portal veins and inflammatory areas in the liver. In addition, renal test results showed casts in the urinary tubules and acute tubular necrosis. According to the results, the co-administration of AOE and BPA could increase the total antioxidative capability, thereby improving the function and structure of the liver and kidney tissues. Therefore, AOE is a potential protective agent against oxidative stress, liver, and kidney damage.Entities:
Keywords: Asparagus Officinalis; Bisphenol A; Kidney; Liver; Rat
Year: 2018 PMID: 29854613 PMCID: PMC5977383 DOI: 10.1016/j.toxrep.2018.02.010
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Body weight (g) and relevant organs weights (g), of control and treated rats.
| Parameter Groups | Body weight (g) | Liver (g) | kidney (g) |
|---|---|---|---|
| Group1 (control) | 245 ± 1.5 | 7.46 ± 1.2b | 1.59 ± 3.4b |
| Group2 (vehicle) | 239 ± 1.5 | 7.24 ± 3.3b | 1.64 ± 1.3b |
| Group3 (AOE) | 235.3 ± 1.4 | 7.29 ± 4.2b | 1.58 ± 4.1b |
| Group4 (BPA) | 228 ± 2.7 | 9.35 ± 3.5a | 3.51 ± 2.3a |
| Group5(BPA + AOE) | 234 ± 1.5 | 7.88 ± 4.1b | 1.63 ± 3.7b |
Values are presented as mean ±S.E. (n = 8 animals/group). Letters a and b in each column indicate significant differences at p ≤ 0.05.
Effects of BPA exposure alone and after AOE administration, on liver function biomarker in the serum.
| Parameter Groups | AST (UL−1) | ALT (UL−1) | ALP (UL−1) | Bilirubin (mg dL−1) |
|---|---|---|---|---|
| Group1 (control) | 141.8 ± 4.05b | 71.4 ± 1.08b | 413 ± 2.05b | 0.28 ± 0.44b |
| Group2 (vehicle) | 173.4 ± 2.72b | 77 ± 1.69b | 553 ± 1.92b | 0.26 ± 0.54b |
| Group3 (AOE) | 171.6 ± 4.15b | 68.4 ± 1.27b | 491 ± 1.4b | 0.28 ± 0.44b |
| Group4 (BPA) | 627.4 ± 1.1a | 151.6 ± 4.76a | 1239 ± 4.46a | 0.72 ± 1.3a |
| Group5(BPA + AOE) | 171.8 ± 3.94b | 87.1 ± 4.65b | 680 ± 3.82b | 0.3 ± 0.7b |
Values are presented as mean ±S.E. (n = 8 animals/group). Letters a and b in each column indicate significant differences at p ≤ 0.05.
Effects of BPA exposure alone and after AOE administration on serum urea and creatinine levels of control and treated rats.
| Parameter Groups | Urea (mg dL−1) | Creatinine (mg dL−1) |
|---|---|---|
| Group1 (control) | 22 ± 1.7b | 0.74 ± 0.54b |
| Group2 (vehicle) | 25.8 ± 3.27b | 0.8 ± 0.7b |
| Group3 (AOE) | 23.8 ± 0.83b | 0.76 ± 0.5b |
| Group4 (BPA) | 47.2 ± 4.79a | 2.76 ± 1.1a |
| Group5(BPA + AOE) | 27 ± 3.8b | 0.76 ± 0.54b |
Values are presented as mean ±S.E. (n = 8 animals/group). Letters a and b in each column indicate significant differences at p ≤ 0.05.
Effects of BPA exposure alone and after AOE administration, on MDA, G-SH and AOA in the serum.
| Parameter Groups | MDA (nmol ml−1) | G-SH (μmol ml−1) | TAC |
|---|---|---|---|
| Group1 (control) | 501 ± 6.4b | 45.4 ± 6a | 538 ± 3.12a |
| Group2 (vehicle) | 498 ± 3.3b | 48.2 ± 3.6a | 521 ± 1.28a |
| Group3 (AOE) | 487 ± 5.4b | 46.5 ± 1.4a | 539 ± 2.4a |
| Group4 (BPA) | 687 ± 3.1a | 28.6 ± 4.3b | 472 ± 3.2b |
| Group5(BPA + AOE) | 513 ± 1.4b | 40.3 ± 5.6a | 505 ± 4.6a |
Values are presented as mean ±S.E. (n = 8 animals/group). Letters a and b in each column indicate significant differences at p ≤ 0.05.
Fig. 1Light photomicrographs of the liver: (a) Control group: Shows a central vein (star) with hepatocyte arranged in cords. Cords of hepatocytes enclose blood sinusoids (arrow); (H&E, X400). (b) BPA treated group: Some hepatocytes show dark nuclei and dense acidophilic cytoplasm (arrow); (H&E, X400). (c) BPA treated group: Dilated and congested central veins (star): (H&E, X100). (d) BPA treated group: Dilated sinusoids with increased proliferation of kupffer cells (arrow); (H&E, X400). (e) BPA treated group: shows lymphocytic infiltration and mild inflammatory areas (arrows); (H&E, X400). (f) BPA + AOE group: Shows normal central vain (star) without any congestion and ameliorated cords of hepatocytes enclose blood sinusoids (arrow); (H&E, X400).
Fig. 2Light photomicrographs of the kidney: (a) Control group: normal renal glomeruli (star) and proximal convoluted tubules (Thick arrow), distal tubules (Thin arrow); (H&E, X400). (b) BPA treated group: glomerular destruction and congestion (star); (H&E, X400). (c) BPA treated group: showing hyaline casts (arrow), in some tubules (H&E, X400). (d) BPA treated group: some tubules with damaged epithelial cells (arrow); (H&E, X400). (e) BPA + AOE group: Shows normal renal glomeruli and tubules, without any congestion or damaged cells (H&E, X400).